Kevin Gardinier
Vice President Discovery Research at Karuna Therapeutics- Claim this Profile
Click to upgrade to our gold package
for the full feature experience.
Topline Score
Bio
Experience
-
Karuna Therapeutics
-
United States
-
Biotechnology
-
100 - 200 Employee
-
Vice President Discovery Research
-
Sep 2021 - Present
-
-
-
Novartis Institutes for BioMedical Research (NIBR)
-
United States
-
Pharmaceutical Manufacturing
-
700 & Above Employee
-
Director of Medicinal Chemistry - Neuroscience and Nephrology
-
Oct 2016 - Sep 2021
- Portfolio responsibilities across neuroscience and nephrology to shape scientific strategy, manage resources, and develop talent. - Experienced leader with excellent cross-functional collaboration skills focused on establishing an integrated scientific strategy from target identification through lead optimization. - Developed a multi-dimensional Targeted Protein Degradation (TPD) approach to treat CNS proteinopathies. - Portfolio responsibilities across neuroscience and nephrology to shape scientific strategy, manage resources, and develop talent. - Experienced leader with excellent cross-functional collaboration skills focused on establishing an integrated scientific strategy from target identification through lead optimization. - Developed a multi-dimensional Targeted Protein Degradation (TPD) approach to treat CNS proteinopathies.
-
-
-
Eli Lilly and Company
-
United States
-
Pharmaceutical Manufacturing
-
700 & Above Employee
-
Research Advisor and Neuroscience Group Leader
-
Feb 2000 - Sep 2016
Extensive lead generation and optimization experience in neuroscience research focused on neurodegenerative diseases (tau pathology), ligand-gated and voltage-gated ion channel targets for the treatment of epilepsy and pain, and on cell surface targets to treat diseases related to obesity and anxiety/depression. Extensive lead generation and optimization experience in neuroscience research focused on neurodegenerative diseases (tau pathology), ligand-gated and voltage-gated ion channel targets for the treatment of epilepsy and pain, and on cell surface targets to treat diseases related to obesity and anxiety/depression.
-
-
-
-
Research Assistant
-
Jun 1994 - Aug 1994
Synthesized linkers for combinatorial chemistry. Developed novel 3-dimensional support linkers. Synthesized linkers for combinatorial chemistry. Developed novel 3-dimensional support linkers.
-
-
Education
-
University of California, Berkeley
Ph.D., Organic Synthesis, Natural Products -
Université Louis Pasteur (Strasbourg I)
Post-Doc with Nobel Laureate Jean-Marie Lehn, Synthetic Chemistry, Molecular Recognition -
Colgate University
Bachelor of Arts (B.A.), Organic Chemistry